Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Feasibility of Wearable-Based Remote Monitoring in Patients During Intensive Treatment for Aggressive Hematologic Malignancies.
Jacobsen M, Rottmann P, Dembek TA, Gerke AL, Gholamipoor R, Blum C, Hartmann NU, Verket M, Kaivers J, Jäger P, Baermann BN, Heinemann L, Marx N, Müller-Wieland D, Kollmann M, Seyfarth M, Kobbe G. Jacobsen M, et al. Among authors: kaivers j. JCO Clin Cancer Inform. 2022 Jan;6:e2100126. doi: 10.1200/CCI.21.00126. JCO Clin Cancer Inform. 2022. PMID: 35025669 Free article.
Novel therapies in low- and high-risk myelodysplastic syndrome.
Germing U, Schroeder T, Kaivers J, Kündgen A, Kobbe G, Gattermann N. Germing U, et al. Among authors: kaivers j. Expert Rev Hematol. 2019 Oct;12(10):893-908. doi: 10.1080/17474086.2019.1647778. Epub 2019 Jul 31. Expert Rev Hematol. 2019. PMID: 31353975 Review.
EASIX for prediction of survival in lower-risk myelodysplastic syndromes.
Merz A, Germing U, Kobbe G, Kaivers J, Jauch A, Radujkovic A, Hummel M, Benner A, Merz M, Dreger P, Luft T. Merz A, et al. Among authors: kaivers j. Blood Cancer J. 2019 Nov 11;9(11):85. doi: 10.1038/s41408-019-0247-z. Blood Cancer J. 2019. PMID: 31712595 Free PMC article. Clinical Trial.
Improving the accuracy of prognostication in chronic myelomonocytic leukemia.
Kaivers J, Schuler E, Hildebrandt B, Betz B, Rautenberg C, Haas R, Kobbe G, Gattermann N, Germing U. Kaivers J, et al. Expert Rev Anticancer Ther. 2020 Aug;20(8):703-714. doi: 10.1080/14737140.2020.1796644. Epub 2020 Aug 6. Expert Rev Anticancer Ther. 2020. PMID: 32700646 Review.
Prediction of Response and Survival Following Treatment with Azacitidine for Relapse of Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Stem Cell Transplantation.
Rautenberg C, Bergmann A, Germing U, Fischermanns C, Pechtel S, Kaivers J, Jäger P, Schuler E, Haas R, Kobbe G, Schroeder T. Rautenberg C, et al. Among authors: kaivers j. Cancers (Basel). 2020 Aug 12;12(8):2255. doi: 10.3390/cancers12082255. Cancers (Basel). 2020. PMID: 32806572 Free PMC article.
Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Schuler E, Wagner-Drouet EM, Ajib S, Bug G, Crysandt M, Dressler S, Hausmann A, Heidenreich D, Hirschbühl K, Hoepting M, Jost E, Kaivers J, Klein S, Koldehoff M, Kordelas L, Kriege O, Müller LP, Rautenberg C, Schaffrath J, Schmid C, Wolff D, Haas R, Bornhäuser M, Schroeder T, Kobbe G; German Cooperative Transplant Study Group. Schuler E, et al. Among authors: kaivers j. Ann Hematol. 2021 Apr;100(4):959-968. doi: 10.1007/s00277-020-04321-x. Epub 2020 Nov 16. Ann Hematol. 2021. PMID: 33191481 Free PMC article.
24 results